​​December 12, 2016
LEVO THERAPEUTICS' COLLABORATING INVESTIGATORS PUBLISH DISCOVERY OF NOVEL TARGET FOR PRADER-WILLI SYNDROME



October 27, 2016

LEVO THERAPEUTICS TO LICENSE EXCLUSIVE RIGHTS TO FERRING PHARMACEUTICALS' ORPHAN-DESIGNATED DRUG, CARBETOCIN, FOR THE TREATMENT OF PRADER-WILLI SYNDROME

​​​​​​​levo therapeutics